Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term: breast cancer cell

Results 1 - 100 of 243 > >>
EC Number
Source Tissue
Commentary
Reference
15-hydroxyprostaglandin dehydrogenase (NAD+)
-
15-hydroxyprostaglandin dehydrogenase (NAD+)
expression of the enzyme and the estrogen receptor is correlated
3beta-hydroxy-DELTA5-steroid dehydrogenase
-
3beta-hydroxy-DELTA5-steroid dehydrogenase
3beta-hydroxysteroid dehydrogenase type 1
3beta-hydroxy-DELTA5-steroid dehydrogenase
isozyme 3beta-HSD1
prostaglandin-F synthase
18fold increase in the median AKR1C3 mRNA levels in breast cancer patients as compared to those without disease
prostaglandin-F synthase
of invasive ductal carcinoma of the breast, immunohistochemical analysis; of invasive ductal carcinoma of the breast, immunohistochemical analysis
3alpha-hydroxysteroid 3-dehydrogenase (Re-specific)
-
L-lactate dehydrogenase
-
L-lactate dehydrogenase
normal and malignant human breast tissues. The enzyme is highly expressed in breast
3beta-hydroxysteroid 3-dehydrogenase
selective expression of 3beta-HSD1
3alpha-hydroxysteroid 3-dehydrogenase
-
3alpha-hydroxysteroid 3-dehydrogenase (Si-specific)
-
17beta-estradiol 17-dehydrogenase
17beta-HSD1 is overexpressed in many breast tumors
glycerol-3-phosphate dehydrogenase (NAD+)
-
phospholipid-hydroperoxide glutathione peroxidase
-
arachidonate 15-lipoxygenase
-
peptide-aspartate beta-dioxygenase
-
peptide-aspartate beta-dioxygenase
highly expressed
procollagen-proline 4-dioxygenase
P4HA2 mRNA levels are significantly upregulated in breast cancer compared to normal mammary tissue
[histone H3]-dimethyl-L-lysine36 demethylase
-
procollagen-lysine 5-dioxygenase
-
mRNA N6-methyladenine demethylase
-
[histone H3]-trimethyl-L-lysine9 demethylase
-
[histone H3]-trimethyl-L-lysine9 demethylase
JMJD1A is expressed in human cancers such as glioblastoma and breast cancer in vivo, and expression is associated with the hypoxic marker CA9
[histone H3]-trimethyl-L-lysine4 demethylase
high expression level of JARID1B
procollagen-proline 3-dioxygenase
;
flavin-containing monooxygenase
-
heme oxygenase (biliverdin-producing)
;
calcidiol 1-monooxygenase
-
calcidiol 1-monooxygenase
the enzyme expression is reduced in breast cancer cell specimen compared to healthy breast tissue
sphingolipid 4-desaturase
-
superoxide dismutase
harbors MnSOD with the ala16val polymorphism
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)
-
aldehyde dehydrogenase (NAD+)
-
L-aminoadipate-semialdehyde dehydrogenase
-
dihydropyrimidine dehydrogenase (NAD+)
-
protein-lysine 6-oxidase
-
protein-lysine 6-oxidase
circulating; circulating
protein-lysine 6-oxidase
hypoxic
protein-lysine 6-oxidase
lymph node-negative breast adenocarcinoma cell
N1-acetylpolyamine oxidase
-
NAD(P)H oxidase (H2O2-forming)
-
thioredoxin-disulfide reductase
-
thiol oxidase
expression analysis of a panel of cDNAs derived from 50 clinically-graded normal and malignant breast tissue samples for the expression of QSOX1 mRNAs, significant correlation between relative transcript level and clinical grade malignant breast tumors
protein-S-isoprenylcysteine O-methyltransferase
-
phosphatidylethanolamine N-methyltransferase
-
tRNA (adenine58-N1)-methyltransferase
-
protein N-terminal methyltransferase
-
catechol O-methyltransferase
-
glycine hydroxymethyltransferase
expression patterns of SHMT2 in 76 breast cancer patients after modified radical mastectomy, immunohistochemic analysis, SHMT2 is highly expressed in breast cancer cells, and the expression level of SHMT2 is positively correlated with breast cancer grade
transketolase
TKTL1 expression in 86% of breast cancer specimens with 45% showing high expression levels
phosphatidylcholine-retinol O-acyltransferase
neoplastic and adjacent, non-neoplastic glandular breast tissue specimens from human patients, expression analysis, reduced enzyme expression, LRAT protein progressively decreases with a reduction in the degree of tumor differentiation in invasive breast carcinomas, overview
sphingosine N-acyltransferase
-
N-acetylneuraminate 7-O(or 9-O)-acetyltransferase
-
histone acetyltransferase
-
arylamine N-acetyltransferase
-
arylamine N-acetyltransferase
methylation status and the transcriptional activity of NAT1 in breast cancer tissues: methylation of NAT1 gene is identified in 39 of the breast carcinomas (54.2%), 23 normal (76.7%) and 25 benign breast tissue samples (80.6%). Breast cancer tissues show significantly lower methylation rates of the NAT1 promoters than the normal and benign tissues. Cancer tissues show lower methylation density rates than normal and benign breast tissues. Tissues that show aberrant methylation of NAT1 show significantly less mRNA expression compared with the unmethylated cases. 20 cancers from the methylated group show positive staining for the estrogen receptor (ER) (51.3%), while 72.7% from the unmethylated group stain positive
arylamine N-acetyltransferase
NAT1 is overexpressed in estrogen receptor-positive breast cancer
arylamine N-acetyltransferase
patients with ductal carcinoma; patients with ductal carcinoma
diamine N-acetyltransferase
in breast tumors, SSAT is increased contributing to an increase in acetylated polyamines
fatty-acid synthase system
-
protein-glutamine gamma-glutamyltransferase
MDA-MB-231 (doxorubicin resistant) human breast cancer cell
gamma-glutamyltransferase
-
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase
-
alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase
-
hyaluronan synthase
-
O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
manic fringe is highly expressed in claudin-low breast cancer
protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase
-
ceramide glucosyltransferase
-
nicotinamide phosphoribosyltransferase
-
uridine phosphorylase
-
uridine phosphorylase
negative correlation between UPase expression and the clinical outcome of breast cancer
NAD+ ADP-ribosyltransferase
-
alpha-N-acetylneuraminate alpha-2,8-sialyltransferase
-
alpha-N-acetylneuraminate alpha-2,8-sialyltransferase
tissue samples of primary invasive breast cancer cases
lactosylceramide alpha-2,3-sialyltransferase
-
protein geranylgeranyltransferase type II
-
6-phosphofructo-2-kinase
-
phosphatidylinositol 3-kinase
-
phosphatidylinositol 3-kinase
ER-positive breast cancer cells (UMB-1Ca) are grown as tumors in ovariectomized athymic nude mice
ceramide kinase
CERK expression is associated with an increased risk of recurrence in women with breast cancer
ceramide kinase
tissue samples of primary invasive breast cancer cases
phosphatidylinositol-4,5-bisphosphate 3-kinase
-
phosphatidylinositol-4-phosphate 3-kinase
isozyme PI3K-C2beta is overexpressed in human breast cancer cell lines
1-phosphatidylinositol 4-kinase
non-specific infiltrating duct and infiltrating lobular carcinomas
sphingosine kinase
-
acylglycerol kinase
enzyme overexpression
receptor protein-tyrosine kinase
-
receptor protein-tyrosine kinase
EphA2 forms a complex with ErbB2, resulting in enhanced activation of Ras-MAPK signaling and RhoA GTPase
receptor protein-tyrosine kinase
overexpression of EGFR-TK
receptor protein-tyrosine kinase
overexpression of Her2-receptor
receptor protein-tyrosine kinase
overexpression of Ron
non-specific protein-tyrosine kinase
breast cancer
non-specific protein-tyrosine kinase
breast carcinomas
Results 1 - 100 of 243 > >>